1 PANTOPRAZOLE SODIUM | 2280 of 8830 | 1350 prescriptions Less than 1% of all prescriptions | 1240 | 420 patients 18% of all patients | < 11 | |
2 OMEPRAZOLE | 3130 of 9090 | 780 prescriptions Less than 1% of all prescriptions | | 260 patients 11% of all patients | < 11 | |
3 FAMOTIDINE | 1170 of 3840 | 310 prescriptions Less than 1% of all prescriptions | 310 | < 11 | < 11 | |
4 DEXILANT (DEXLANSOPRAZOLE) | 760 of 4830 | 390 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
5 ESOMEPRAZOLE MAGNESIUM | 770 of 5080 | 190 prescriptions Less than 1% of all prescriptions | 190 | < 11 | < 11 | |
6 DICYCLOMINE HCL | 1510 of 6190 | 210 prescriptions Less than 1% of all prescriptions | | 130 patients 6% of all patients | < 11 | |
7 BUDESONIDE EC (BUDESONIDE) | 260 of 2990 | 340 prescriptions Less than 1% of all prescriptions | 340 | < 11 | < 11 | |
8 PENTASA (MESALAMINE) | 160 of 670 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
9 CREON (LIPASE/PROTEASE/AMYLASE) | 480 of 2900 | 190 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
10 WELCHOL (COLESEVELAM HCL) | 260 of 660 | 180 prescriptions Less than 1% of all prescriptions | 180 | < 11 | < 11 | |
11 FUROSEMIDE | 440 of 2140 | 140 prescriptions Less than 1% of all prescriptions | 140 | < 11 | < 11 | |
12 APRISO (MESALAMINE) | 440 of 3180 | 150 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
13 ENTECAVIR | 190 of 550 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
14 SUPREP (SODIUM, POTASSIUM,MAG SULFATES) | 1870 of 5270 | 540 prescriptions Less than 1% of all prescriptions | | 540 patients 23% of all patients | < 11 | |
15 PEG 3350-ELECTROLYTE (SODIUM CHLORIDE/NAHCO3/KCL/PEG) | 870 of 2220 | 180 prescriptions Less than 1% of all prescriptions | | 170 patients 7% of all patients | < 11 | |
16 GAVILYTE-N (SODIUM CHLORIDE/NAHCO3/KCL/PEG) | 890 of 2030 | 150 prescriptions Less than 1% of all prescriptions | | 150 patients 6% of all patients | < 11 | |